Kotak Small Cap Fund Regular-Growth
The fund is rated 0 stars. The balance between returns and downside risk provided limited support. Investment selection within each asset type and investment selection within each industry were the main limitations and did not provide enough support for a higher rating. Above-average fund size of Rs 19,678.75 crore was a minor drawback.
This fund has a bad track record with Asset Selection/Timing, a bad track record with Stock Selection/Timing. It is important to note, however, that this fund has a 19678.753 AUM and a 1.725 expense ratio. Considering all these factors, we have rated this fund as 0.0 star.
आमचा स्कोअर दीर्घकालीन कामगिरी, जोखीम आणि सातत्य यांचे वजन करतो — फक्त मागील परतावे नाही.
परतावा
8 Oct 2026 पर्यंत
जोखीम गुणोत्तरे
30 Sep 2026 पर्यंत
पोर्टफोलिओ
31 Aug 2026 पर्यंत
मार्केट-कॅप विभागणी
क्षेत्रनिहाय वाटप
होल्डिंग्स (80)
| होल्डिंग | फंडाचा % | मूल्य | शेअर्स |
|---|---|---|---|
| Aster DM Quality Care Ltd. | 4.29% | ₹844.29 Cr | 1,11,67,820 |
| Vijaya Diagnostic Centre Ltd. | 4.21% | ₹828.24 Cr | 54,54,656 |
| Sansera Engineering Ltd. | 4.15% | ₹816.78 Cr | 20,32,796 |
| Krishna Institute of Medical Sciences Ltd | 3.25% | ₹638.71 Cr | 84,54,118 |
| Kalpataru Projects International Ltd. | 2.54% | ₹500.42 Cr | 35,72,133 |
| Minda Corporation Ltd. | 2.39% | ₹470.8 Cr | 66,07,215 |
| Century Plyboards (India) Ltd. | 2.25% | ₹441.99 Cr | 58,36,731 |
| Five-Star Business Finance Ltd. | 2.12% | ₹416.28 Cr | 77,80,174 |
| Shriram Finance Ltd | 2.03% | ₹399.95 Cr | 36,03,518 |
| Ajanta Pharma Ltd. | 1.99% | ₹391.21 Cr | 10,86,134 |
फंड तपशील
Long term capital growth. Investment in equity & equity related securities predominantly in small cap Stocks.
The scheme seeks to generate capital appreciation from a diversified portfolio of equity and equity related securities by investing predominantly in small cap companies.
Exit load for units in excess of 10% of the investment,1% will be charged for redemption within 365 days